Intellia Therapeutics, Inc. (NTLA): DEFA14A filed Apr 30, 2026

Form type

DEFA14A

Filing date

Apr 30, 2026

Accession number

0001193125-26-197355

Filer

Intellia Therapeutics, Inc. (CIK 1652130)